Brachytherapy
Volume 7, Issue 1 , Pages 37-42 , January 2008

Image-guided cervix high-dose-rate brachytherapy treatment planning: Does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?

  • Melanie T.M. Davidson

      Affiliations

    • Department of Clinical Physics and Engineering, The London Regional Cancer Program, London, Ontario, Canada
    • ,
  • Jasper Yuen

      Affiliations

    • Department of Radiation Oncology, The London Regional Cancer Program, London, Ontario, Canada
    • ,
  • David P. D'Souza

      Affiliations

    • Department of Radiation Oncology, The London Regional Cancer Program, London, Ontario, Canada
    • ,
  • Deidre L. Batchelar

      Affiliations

    • Department of Clinical Physics and Engineering, The London Regional Cancer Program, London, Ontario, Canada
    • Corresponding Author InformationCorresponding author. Medical Physics Department, Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. Tel.: +1-416-480-6100 ext. 1092; fax: +1-416-480-6801.

Received 11 July 2007 ,Accepted 18 December 2007.

References 

  1. Nori D, Dasari N, Allbright RM. Gynecologic brachytherapy I: Proper incorporation of brachytherapy into the current multimodality management of carcinoma of the cervix. Semin Radiat Oncol. 2002;12:40–52
  2. Pötter R, Dimopoulos J, Georg P, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol. 2007;83:148–155
  3. Viswanathan AN, Dimopoulos J, Kirisits C, et al. Computed tomography versus magnetic imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys. 2007;68:491–498
  4. Nag S, Cardenes H, Chang S, et al. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: Report from image-guided brachytherapy working group. Int J Radiat Oncol Biol Phys. 2004;60:1160–1172
  5. Garipağaoğlu M, Tunçel N, Dalmaz MG, et al. Changes in applicator positions and dose distribution between high dose rate brachytherapy fractions in cervix carcinoma patients receiving definitive radiotherapy. Br J Radiol. 2006;79:504–509
  6. Bahena JH, Martinez A, Di Yan F, et al. Spatial reproducibility of the ring and tandem high-dose rate cervix applicator. Int J Radiat Oncol Biol Phys. 1998;41:13–19
  7. Datta NR, Kumar S, Das KJM, et al. Variations of intracavitary applicator geometry during multiple HDR brachytherapy insertions in carcinoma cervix and its influence on reporting as per ICRU report 38. Radiother Oncol. 2001;60:15–24
  8. Hellebust TP, Dale E, Skjønsberg A, et al. Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations. Radiother Oncol. 2001;60:273–280
  9. Kirisits C, Pötter R, Lang S, et al. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005;62:901–911
  10. Kirisits C, Lang S, Dimopoulos J, et al. Uncertainties when using only one MRI-based treatment plan for subsequent high-dose-rate tandem and ring applicators in brachytherapy of cervix cancer. Radiother Oncol. 2006;81:269–275
  11. Haie-Meder C, Pötter R, Van Limbergen E, et al. Recommendations from Gynecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74:235–245
  12. International Commission on Radiation Units and Measurements (ICRU) . ICRU Report 38: dose and volume specification for reporting intracavitary brachytherapy in gynecology. Baltimore, MD: ICRU; 1985;p. 1–16
  13. Perez CA, Grigsby PW, Lockett MA, et al. Radiation therapy morbidity in carcinoma of the uterine cervix: Dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys. 1999;44:855–866
  14. Jones ND, Rankin J, Gaffney DK. Is simulation necessary for each high-dose-rate tandem and ovoid insertion in carcinoma of the cervix?. Brachytherapy. 2004;3:120–124
  15. Erickson BA. The sculpted pear: An unfinished brachytherapy tale. Brachytherapy. 2003;2:189–199
  16. Stuecklschweiger GF, Arian-Schad KS, Poier E, et al. Bladder and rectal dose of gynecologic high-dose-rate implants: Comparison of orthogonal radiographic measurements with in vivo and CT-assisted measurements. Radiology. 1991;181:889–894
  17. Kapp KS, Stuecklschweiger GF, Kapp DS, et al. Dosimetry of intracavitary placements for uterine and cervical carcinoma: Results of orthogonal film, TLD, and CT-assisted techniques. Radiother Oncol. 1992;24:137–146
  18. Pelloski CE, Palmer M, Chronowski GM, et al. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to the bladder and rectum during intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005;62:131–137
  19. Wachter-Gerstner N, Wachter S, Reinstadler E, et al. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: Comparison with ICRU rectum and bladder reference point. Radiother Oncol. 2003;68:269–276
  20. Chow H, Lane R, Rosen I. Uncertainty in dose estimation for gynecological implants. Int J Radiat Oncol Biol Phys. 1990;19:1555–1559
  21. Krishnan L, Cytacki E, Wolf C, et al. Dosimetric analysis in brachytherapy of the cervix. Int J Radiat Oncol Biol Phys. 1990;18:965–970
  22. Kim RY, Pareek P. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: Analysis of dose-volume histograms. Brachytherapy. 2003;2:200–206
  23. Schoeppel SL, LaVigne ML, Martel MK, et al. Three dimensional treatment planning of intracavitary gynecologic implants: Analysis of ten cases and implications for dose specification. Int J Radiat Oncol Biol Phys. 1994;28:277–283
  24. Al-Booz H, Bioangiu I, Appleby H, et al. Sigmoid colon is an unexpected organ at risk in brachytherapy for cervix cancer. J Egyp Nat Cancer Inst. 2006;18:156–160

PII: S1538-4721(07)00283-8

doi: 10.1016/j.brachy.2007.12.003

Brachytherapy
Volume 7, Issue 1 , Pages 37-42 , January 2008

Article Tools

* Image Usage & Resolution